Business
Mitie : FY26 Results Presentation
Mitie : FY26 Results

About this update from Mitie Group Plc
Good performance in FY26; confidence in delivering FY25-FY27 Strategic Plan; foundations in place for FY28+ Results presentation for the year ended 31 March 2026 The future of high-performing places FY26 highlights 2 Double-digit growth in revenue and op. profit for third consecutive year Strong Growth Operating margin up, despite material cost headwinds Resilience Record order book, majority delivered in next 3 years, and bidding pipeline High Visibility Good FCF and low leverage underpin £100m of share buybacks in FY27 Cash Generative Initial Marlowe revenue and cost synergies delivered M&A Confidence in delivering our FY25-FY27 Strategic Plan Positive Outlook Strategic foundations in place for next phase of growth, FY28+ Value Creation 3 FY26 highlights in charts Growth indicators Wins/renewals 2 : £6.3bn FCF & capital deployment Free cash flow: £162m -16% YoY (£bn) 14% 8 CAGR 4 0 FY23 FY24 FY25 FY26 +13% YoY (£m) 200 100 0 35% CAGR FY23 FY24 FY25 FY26 Order book: £16.3bn Capital deployments 3 : £414m +6% YoY (£bn) 16 19% 14 CAGR 12 10 8 FY23 FY24 FY25 FY26 +75% YoY (£m) 500 250 0 44% CAGR FY23 FY24 FY25 FY26 Pipeline: £31.7bn Full year dividend: 4.5p 4 +34% YoY (£bn) 35 29% 30 CAGR 25 20 15 10 FY23 FY24 FY25 FY26 +5% YoY (p/share) 16% 5 CAGR 4 3 2 FY23 FY24 FY25 FY26 1 Operating profit and Basic EPS before Other items. 2 Total Contract Value; FY24 wins are adjusted for Landmarc consolidation (£451m) 3 Including dividends, share buybacks, share purchases for incentive schemes and M&A. 4 Subject to shareholder approval at AGM. FY23 FY24 FY25 FY26 5 10 CAGR 15 +7% YoY (p/share) Basic EPS 1 : 13.6p 13% FY23 FY24 FY25 FY26 100 200 18% 300 CAGR +13% YoY (£m) FY23 FY24 FY25 FY26 Operating profit 1 : £264m 13% CAGR 6 5 4 3 +11% YoY (£bn) Financial performance Revenue: £5.6bn 4 Financial update Simon Kirkpatrick Chief Financial Officer 2023 Capital Markets Event (CME) High single digit revenue growth (CME baseline: £4.4bn) Operating profit margin >5% FY27 Financial Targets (CME baseline: 4.0 - 4.5%) EPS growth > revenue growth (CME baseline: 10.5 - 11.0p) 5 Durable financial model : compounding earnings, value accretion, increased shareholder returns FCF generation of c.£150m p.a. (CME baseline: >£100m) ROIC >20% (CME baseline: c.25%) 'CME Baseline' represents the FY24 financial forecasts on which the 3YP growth rates and targets were set at the October 2023 CME 1 Before other items 7 upgrades to FY26 consensus profit since CME (CME FY26 consensus £207m vs FY26 actual of £264m) Value accretion and shareholder returns (2 yr TSR 79%) Long term compounding earnings (2 yr EPS CAGR +13%) FY26 CME Base FY25 400 +37% 300 CAGR 200 100 CME Base FY25 FY26 Capital deployment £414m 160.0 140.0 120.0 100.0 80.0 +16% CAGR Cash generation Free cash flow: £162m Growth Revenue: £5.6bn +13% CAGR 6.0 4.0 2.0 CME Base FY25 FY26 Order book: £16.3bn +24% CAGR 16.0 13.0 10.0 7.0 4.0 CME Base FY25 FY26 Profitability Op. profit 1 : £264.1m +18% CAGR 250 200 150 100 CME Base FY25 FY26 Op. profit margin: 4.7% +40bps 5.0% 4.8% 4.6% 4.4% 4.2% 4.0% CME Base FY25 FY26